Article
Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jan 2006
Digianni Lisa M, Rue Montserrat, Emmons Karen, Garber Judy E
Abstract excerpt
PURPOSE: We explored change in complementary and alternative medicine (CAM) use by unaffected women and cancer survivors from enrollment into a randomized BRCA1/2 testing program to CAM use 1 year following results disclosure. METHODS: A cohort of 243 high-risk women completed questionnaires at enrollment into a BRCA1/2 randomized trial and 1 year post results disclosure. Uses of several CAMs for cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.